News

Pharma-Sponsored Comparison Studies Hold Clinical Value


 

EXPERT ANALYSIS FROM THE COASTAL DERMATOLOGY SYMPOSIUM

Methotrexate Vs. Azathioprine for Atopy

In the treatment of severe atopic dermatitis, methotrexate and azathioprine were found to be almost equal in efficacy (42% vs. 39%, respectively). Patients (52 completed the study) were randomized to receive 10-22.5 mg of methotrexate per week or 1.5-2.2 mg/kg per day for 12 weeks (J. Allergy Clin. Immunol. 2011;128:353-9). Outcome was assessed by blinded reviewers.

"I think that the adverse event profile of methotrexate in most people is much better, so I tend to disagree with the outcome of this study," said Dr. Fowler.

Dr. Fowler reported financial conflicts of interest with multiple pharmaceutical companies, including many of the products mentioned during his presentation.



Pages

Recommended Reading

Two Doses May Be Good as Three With HPV Vaccine
MDedge Pediatrics
Most Children Who Died From Flu Weren't Vaccinated
MDedge Pediatrics
Doripenem Knocks Out Tough Pediatric Infections
MDedge Pediatrics
HPV Vaccine Safe, Effective in Girls with JIA
MDedge Pediatrics
Routine Rotavirus Vaccination May Reduce Health Care Costs
MDedge Pediatrics
What's New With Flu? For Doctors, Vaccination by Example
MDedge Pediatrics
Bedbug Insecticides More Harmful Than the Pest
MDedge Pediatrics
E. Coli O26 Data Point to a "Low-Virulence Pathogen"
MDedge Pediatrics
AAP Updates Polio Protection Policy
MDedge Pediatrics
One in 10 Parents Opt For Alternative Vaccination Schedules
MDedge Pediatrics